本文翻译正在准备中。在此之前，我们暂时显示英文原文。
创新与知识产权 · 1996/5/221 分钟阅读
Notice of Two Year Exclusivity Period; DAYPRORegister Oxaprozin
本地自动翻译 · 来源原始语言
摘要
The Patent and Trademark Office has received notification from G. D. Searle & Co. that it claims entitlement under section 2105 of the FDA Export Reform and Enhancement Act of 1996 (Chapter 1A of Pub. L. No. 104-134) for its drug product DAYPRO oxaprozin.
来源原始语言: Federal Register — Patent and Trademark Office打开原始公告 →